Dr. Turk is a board-certified Neurologist specialized in Cognitive and Behavioral Neurology. She earned her medical degree from Tufts University School of Medicine and then completed her Internship and Neurology residency at the University of Washington in Seattle. She completed her fellowship training in Behavioral Neurology at Boston University/VA Boston. She sees patients at the Boston VA Memory Disorders clinic and is also a principal investigator and co-director of the Center for Translational Cognitive Neuroscience lab (CTCN) at VA Boston. She serves as the co-Leader of the Outreach, Recruitment and Engagement core of the Boston University Alzheimer’s disease Research Center. She has received research funding from the Alzheimer’s Association, the Doris Duke Foundation and the US Department of Veterans Affairs. Dr. Turk’s research interests include behavioral interventions for autobiographical memory loss in clinical populations including veterans with Alzheimer’s disease and Traumatic Brain Injury as well the investigation of event-related potentials as clinical diagnostic biomarkers.
- VA Boston Healthcare System
- Tufts University School of Medicine, MD
- University of Chicago, BA
- Published on 6/12/2023
Friedman G, Turk KW, Budson AE. The Current of Consciousness: Neural Correlates and Clinical Aspects. Curr Neurol Neurosci Rep. 2023 Jul; 23(7):345-352. PMID: 37303019.
- Published on 10/21/2022
Morrison MS, Aparicio HJ, Blennow K, Zetterberg H, Ashton NJ, Karikari TK, Tripodis Y, Martin B, Palmisano JN, Sugarman MA, Frank B, Steinberg EG, Turk KW, Budson AE, Au R, Goldstein LE, Jun GR, Kowall NW, Killiany R, Qiu WQ, Stern RA, Mez J, McKee AC, Stein TD, Alosco ML. Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy. Brain. 2022 Oct 21; 145(10):3546-3557. PMID: 35554506.
- Published on 9/12/2022
Marin A, DeCaro R, Schiloski K, Elshaar A, Dwyer B, Vives-Rodriguez A, Palumbo R, Turk K, Budson A. Home-Based Electronic Cognitive Therapy in Patients With Alzheimer Disease: Feasibility Randomized Controlled Trial. JMIR Form Res. 2022 Sep 12; 6(9):e34450. PMID: 36094804.
- Published on 9/1/2022
Price AM, Palumbo R, Marin A, Uppal P, Suh C, Budson AE, Turk KW. Distinguishing Between Genuine and Feigned Dementia Using Event-related Potentials. Cogn Behav Neurol. 2022 Sep 01; 35(3):188-197. PMID: 35830243.
- Published on 8/17/2022
Vives-Rodriguez AL, Schiloski KA, Marin A, Wang R, Hajos GP, Powsner R, DeCaro R, Budson AE, Turk KW. Impact of amyloid PET in the clinical care of veterans in a tertiary memory disorders clinic. Alzheimers Dement (N Y). 2022; 8(1):e12320. PMID: 35992216.
- Published on 8/17/2022
Turk KW, Vives-Rodriguez A, Schiloski KA, Marin A, Wang R, Singh P, Hajos GP, Powsner R, DeCaro R, Budson AE. Amyloid PET ordering practices in a memory disorders clinic. Alzheimers Dement (N Y). 2022; 8(1):e12333. PMID: 35992217.
- Published on 4/20/2022
Frank B, Ally M, Tripodis Y, Puzo C, Labriolo C, Hurley L, Martin B, Palmisano J, Chan L, Steinberg E, Turk K, Budson A, O'Connor M, Au R, Qiu WQ, Goldstein L, Kukull W, Kowall N, Killiany R, Stern R, Stein T, McKee A, Mez J, Alosco M. Trajectories of Cognitive Decline in Brain Donors With Autopsy-Confirmed Alzheimer Disease and Cerebrovascular Disease. Neurology. 2022 Jun 14; 98(24):e2454-e2464. PMID: 35444054.
- Published on 2/9/2022
Turk KW, Geada A, Alvarez VE, Xia W, Cherry JD, Nicks R, Meng G, Daley S, Tripodis Y, Huber BR, Budson AE, Dwyer B, Kowall NW, Cantu RC, Goldstein LE, Katz DI, Stern RA, Alosco ML, Mez J, McKee AC, Stein TD. A comparison between tau and amyloid-ß cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease. Alzheimers Res Ther. 2022 02 09; 14(1):28. PMID: 35139894.
- Published on 12/2/2021
Frank B, Ally M, Brekke B, Zetterberg H, Blennow K, Sugarman MA, Ashton NJ, Karikari TK, Tripodis Y, Martin B, Palmisano JN, Steinberg EG, Simkina I, Turk KW, Budson AE, O'Connor MK, Au R, Goldstein LE, Jun GR, Kowall NW, Stein TD, McKee AC, Killiany R, Qiu WQ, Stern RA, Mez J, Alosco ML. Plasma p-tau181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau. Alzheimers Dement. 2022 Aug; 18(8):1523-1536. PMID: 34854549.
- Published on 8/1/2021
Vives-Rodriguez A, Turk KW, Vassey EA, Singhal T, Cho CH, Budson AE. Reversible Amnestic Cognitive Impairment in a Patient With Brain Sagging Syndrome. Neurol Clin Pract. 2021 Aug; 11(4):e551-e554. PMID: 34484956.
View 17 more publications: View full profile at BUMC